Encephalopathy following the use of OKT3 in renal allograft transplantation.
Shihab
F S
FS
Laboratory of Immunogenetics and Transplantation, Oregon Health Sciences University, Portland 97201.
Barry
J M
JM
Norman
D J
DJ
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001927:Brain Diseases / Q000209:etiology*; D016207:Cytokines / Q000502:physiology*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D016207:Cytokines; D016853:Muromonab-CD3; D001379:Azathioprine; D008775:Methylprednisolone